Ferrex-150
- Form
- Capsule
- Product type
- Mineral
- Serving size
- 1–2 capsules
Ingredients
Supplement Facts
- Serving size
- 1–2 capsules
| Ingredients | Amount | %DV |
|---|---|---|
| IronPolysaccharide-Iron | 150 mg | 833% |
Show other ingredientsHide other ingredients13
Ingredients listed outside the Supplement Facts panel. Amounts and %DV are not required there, so they are not recorded.
| Ingredients | Form |
|---|---|
| Sodium Lauryl Sulfate | — |
| Gelatin | — |
| Microcrystalline Cellulose | — |
| Stearic Acid | — |
| Polyethylene Glycol | — |
| Citric Acid | — |
| Croscarmellose Sodium | — |
| Titanium Dioxide | — |
| Polyvinylpyrrolidone | — |
| FD&C Yellow No. 5 Lake | — |
| FD&C Red No. 40 Lake | — |
| FD&C Red No. 3 Lake | — |
| FD&C Blue No. 1 Lake | — |
Source: DSLD (US NIH) label ID 201596Amounts are as stated on the product label. Check the latest label before you buy.
Where to buy
Intended for
- Adults
Label directions and warnings
Quoted from the label as written. Marketing statements, such as claimed benefits, are not shown.
- Directions
- Dosage and administration: Adults: One or two capsules daily, or as prescribed by a physician.
- Precautions
- Contains FD&C Yellow No. 5 Lake (Tartrazine) as a color additive.
- Contraindications: Ferrex 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications in the use of this dietary supplement.
- The type of anemia and the underlying cause or causes should be determined before initiating supplementation with Ferrex 150. Since the anemia may be a result of a systemic disturbance, such as a recurrent blood loss, the underlying cause or causes should be corrected if possible.
- Patients should not exceed the recommended dosage unless directed by a physician. Patients should be informed that iron products can cause dark or black stools.
- Do not use if blister seals are broken
- To Report Serious Adverse Effects Call: 800-616-2471
- Adverse reactions: Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stool and abdominal pain. Adverse reactions with iron therapy are usually transient. Overdose: The clinical cause of acute iron overdose can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemic, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.
- Precautions: children
- As with all oral iron preparations, Ferrex 150 should be stored out of the reach of children to protect against accidental iron poisoning.
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
- Keep this and all medications out of the reach of children.
- Precautions: pregnancy, nursing, medications
- Although the overall incidence of FD&C Yellow No. 5 Lake (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.
- Since oral iron products interfere with absorption of certain antibiotics, these products should not be taken within two hours of each other.
- Precautions: allergies
- Precautions: This product contains FD&C Yellow No. 5 Lake (tartrazine), which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons.
- Does not contain
- As an organic complex, it contains no free irons.
- Storage
- Store at 25(0)C (77(0)F); excursions permitted to 15(0)-30(0)C (59(0)-86(0)F). See USP Controlled Room Temperature.